New Hematology Drugs
During the last two decades, we have witnessed the approval of numerous new hematology drugs and a complete transformation in how we approach blood cancers. A deeper understanding of the biology of specific hematologic malignancies has exposed numerous new therapeutic targets that were quickly followed by a plethora of novel therapeutic agents. The availability of novel drugs not only continues to […]
Read more
